Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PSTV – Plus Therapeutics Inc

PLUS THERAPEUTICS, Inc.
PSTV
$0.6586
Name : PLUS THERAPEUTICS, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $11,195,936.00
EPSttm : -2.34
finviz dynamic chart for PSTV
PLUS THERAPEUTICS, Inc.
$0.6586
1.95%
$0.0131

Float Short %

7.55

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.36

EPS Last/This Y

1.01

EPS This/Next Y

0.11

Price

0.66

Target Price

6.17

Analyst Recom

1

Performance Q

-44.66

Relative Volume

0.03

Beta

0.96

Ticker: PSTV




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-20PSTV1.37N/AN/A0
2025-03-21PSTV1.165N/AN/A0
2025-03-24PSTV1.13N/AN/A0
2025-03-25PSTV1.425N/AN/A0
2025-03-26PSTV1.47N/AN/A0
2025-03-27PSTV1.535N/AN/A0
2025-03-28PSTV1.165N/AN/A0
2025-03-31PSTV0.96N/AN/A0
2025-04-01PSTV1.01N/AN/A0
2025-04-02PSTV0.934N/AN/A0
2025-04-03PSTV0.7662N/AN/A0
2025-04-04PSTV0.79N/AN/A0
2025-04-07PSTV0.8201N/AN/A0
2025-04-08PSTV0.8001N/AN/A0
2025-04-09PSTV0.82N/AN/A0
2025-04-10PSTV0.7735N/AN/A0
2025-04-11PSTV0.75N/AN/A0
2025-04-14PSTV0.6357N/AN/A0
2025-04-15PSTV0.652N/AN/A0
2025-04-16PSTV0.6613N/AN/A0
2025-04-17PSTV0.6502N/AN/A0
2025-04-18PSTV0.6586N/AN/A0
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-20PSTV1.3826.8- -2.06
2025-03-21PSTV1.1726.8- -2.06
2025-03-24PSTV1.1429.1- -2.06
2025-03-25PSTV1.4329.1- -2.06
2025-03-26PSTV1.4729.1- -2.06
2025-03-27PSTV1.5329.1- -2.06
2025-03-28PSTV1.1629.1- -2.06
2025-03-31PSTV0.9552.0- -1.61
2025-04-01PSTV1.0252.0- -1.61
2025-04-02PSTV0.8952.0- -1.61
2025-04-03PSTV0.7752.0- -1.61
2025-04-04PSTV0.7954.2- -0.94
2025-04-07PSTV0.8154.2- -0.94
2025-04-08PSTV0.8054.2- -0.94
2025-04-09PSTV0.8354.2- -0.94
2025-04-10PSTV0.7754.2- -0.94
2025-04-11PSTV0.7554.2- -0.94
2025-04-14PSTV0.6454.2- -0.94
2025-04-15PSTV0.6554.2- -0.94
2025-04-16PSTV0.6754.2- -0.94
2025-04-17PSTV0.6654.2- -0.94
2025-04-18PSTV0.6654.2- -0.94
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-20PSTV0.005.932.44
2025-03-21PSTV0.005.932.44
2025-03-24PSTV0.001.221.22
2025-03-25PSTV0.001.221.22
2025-03-26PSTV0.001.228.10
2025-03-27PSTV0.001.228.10
2025-03-28PSTV0.001.228.10
2025-03-31PSTV0.002.278.10
2025-04-01PSTV0.002.278.10
2025-04-02PSTV0.002.278.10
2025-04-03PSTV0.002.278.10
2025-04-04PSTV0.002.275.61
2025-04-07PSTV0.002.275.61
2025-04-08PSTV0.002.275.61
2025-04-09PSTV0.002.275.61
2025-04-10PSTV0.002.277.55
2025-04-11PSTV0.002.277.55
2025-04-14PSTV0.002.277.55
2025-04-15PSTV0.002.277.55
2025-04-16PSTV0.002.277.55
2025-04-17PSTV0.002.277.55
2025-04-18PSTV0.002.277.55
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.67

Avg. EPS Est. Current Quarter

-0.36

Avg. EPS Est. Next Quarter

-0.31

Insider Transactions

Institutional Transactions

2.27

Beta

0.96

Average Sales Estimate Current Quarter

1

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

38

Growth Score

25

Sentiment Score

19

Actual DrawDown %

99.2

Max Drawdown 5-Year %

-99.5

Target Price

6.17

P/E

Forward P/E

PEG

P/S

1.92

P/B

P/Free Cash Flow

EPS

-2.06

Average EPS Est. Cur. Y​

-0.94

EPS Next Y. (Est.)

-0.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-222.84

Relative Volume

0.03

Return on Equity vs Sector %

125

Return on Equity vs Industry %

138.4

EPS 1 7Days Diff

0.7

EPS 1 30Days Diff

1.16

EBIT Estimation

PLUS THERAPEUTICS, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 21
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic drug candidate is REYOBIQ, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
stock quote shares PSTV – Plus Therapeutics Inc Stock Price stock today
news today PSTV – Plus Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PSTV – Plus Therapeutics Inc yahoo finance google finance
stock history PSTV – Plus Therapeutics Inc invest stock market
stock prices PSTV premarket after hours
ticker PSTV fair value insiders trading